As it was reported that combination of both TSA and 5-aza-2’-deoxycytidine (5-aza-dC) reactivate the transcription of CHFR in RKO colorectal cancer cells [15], we assessed the effect of those agents on CHFR mRNA level in TNBC cells. The gene discussed is CHFR; the disease is colorectal cancer.